Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer

American Journal of Pathology

Volumn 174, Issue 1, 2009, Pages 297-308

  Fang, Feng ^a   Flegler, Ayanna J ^a   Du, Pan ^a   Lin, Simon ^a   Clevenger, Charles V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCYCLIN; CALVASCULIN; CYCLOPHILIN B; ESTROGEN RECEPTOR ALPHA; GROWTH HORMONE RECEPTOR; HORMONE RECEPTOR; PEPTIDYLPROLYL ISOMERASE; PROGESTERONE RECEPTOR; PROTEIN C MYB;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LINKAGE ANALYSIS; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 58249102087     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080753     Document Type: Article

References (62)

1. Price ER, Zydowsky LD, Jin MJ, Baker CH, McKeon FD, Walsh CT: Human cyclophilin B: a second cyclophilin gene encodes a peptidylprolyl isomerase with a signal sequence. Proc Natl Acad Sci USA 1991, 88:1903-1907
2. Fischer G, Tradler T, Zarnt T: The mode of action of peptidyl prolyl cis/trans isomerases in vivo: binding vs. catalysis. FEBS Lett 1998, 426:17-20
3. Bhattacharyya T, Karnezis AN, Murphy SP, Hoang T, Freeman BC, Phillips B, Morimoto RI: Cloning and subcellular localization of human mitochondrial hsp70. J Biol Chem 1995, 270:1705-1710
4. Kofron JL, Kuzmic P, Kishore V, Colon-Bonilla E, Rich DH: Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 1991, 30:6127-6134
5. Hunter T: Prolyl isomerases and nuclear function. Cell 1998, 92:141-143
6. Huse M, Chen YG, Massague J, Kuriyan J: Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 1999, 96:425-436
7. Lopez-Ilasaca M, Schiene C, Kullertz G, Tradler T, Fischer G, Wetzker R: Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor. J Biol Chem 1998, 273:9430-9434
8. Brazin KN, Mallis RJ, Fulton DB, Andreotti AH: Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci USA 2002, 99:1899-1904
9. Leverson JD, Ness SA: Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol Cell 1998, 1:203-211
10. Mamane Y, Sharma S, Petropoulos L, Lin R, Hiscott J: Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. Immunity 2000, 12:129-140
11. Allain F, Boutillon C, Mariller C, Spik G: Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies. J Immunol Methods 1995, 178:113-120
12. Mariller C, Allain F, Kouach M, Spik G: Evidence that human milk isolated cyclophilin B corresponds to a truncated form. Biochim Biophys Acta 1996, 1293:31-38
13. Le Hir M, Su Q, Weber L, Woerly G, Granelli-Piperno A, Ryffel B: In situ detection of cyclosporin A: evidence for nuclear localization of cyclosporine and cyclophilins. Lab Invest 1995, 73:727-733
14. Price ER, Jin M, Lim D, Pati S, Walsh CT, McKeon FD: Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci USA 1994, 91:3931-3935
15. Klappa P, Freedman RB, Zimmermann R: Protein disulphide isomerase and a lumenal cyclophilin-type peptidyl prolyl cis-trans isomerase are in transient contact with secretory proteins during late stages of translocation. Eur J Biochem 1995, 232:755-764
16. Yurchenko V, O'Connor M, Dai WW, Guo H, Toole B, Sherry B, Bukrinsky M: CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun 2001, 288:786-788
17. Melchior A, Denys A, Deligny A, Mazurier J, Allain F: Cyclophilin B induces integrin-mediated cell adhesion by a mechanism involving CD98-dependent activation of protein kinase C-delta and p44/42 mitogen-activated protein kinases. Exp Cell Res 2008, 314:616-628
18. Pakula R, Melchior A, Denys A, Vanpouille C, Mazurier J, Allain F: Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis. Glycobiology 2007, 17:492-503
19. Fernandes F, Poole DS, Hoover S, Middleton R, Andrei AC, Gerstner J, Striker R: Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. Hepatology 2007, 46:1026-1033
20. Heitman J, Cullen BR: Cyclophilin B escorts the hepatitis C virus RNA polymerase: a viral achilles heel? Mol Cell 2005, 19:145-146
21. Rycyzyn MA, Reilly SC, O'Malley K, Clevenger CV: Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol Endocrinol 2000, 14:1175-1186
22. Rycyzyn MA, Clevenger CV: The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci USA 2002, 99:6790-6795
23. Robida JM, Nelson HB, Liu Z, Tang H: Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro. J Virol 2007, 81:5829-5840
24. Du P, Kibbe WA, Lin SM: lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548
25. Lin SM, Du P, Huber W, Kibbe WA: Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 2008, 36:e11
26. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:Article3
27. Ganter B, Giroux CN: Emerging applications of network and pathway analysis in drug discovery and development. Curr Opin Drug Discov Devel 2008, 11:86-94
28. Fang F, Antico G, Zheng J, Clevenger CV: Quantification of PRL/Stat5 Signaling with a Novel pGL4-CISH Reporter. BMC Biotechnol 2008, 8:11
29. Miller SL, Antico G, Raghunath PN, Tomaszewski JE, Clevenger CV: Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells. Oncogene 2007, 26:4668-4678
30. Malek D, Gust R, Kleuser B: 17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression. Eur J Pharmacol 2006, 534:39-47
31. McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA, Clevenger CV: Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol 2008, 21:565-571
32. Walter-Yohrling J, Cao X, Callahan M, Weber W, Morgenbesser S, Madden SL, Wang C, Teicher BA: Identification of genes expressed in malignant cells that promote invasion. Cancer Res 2003, 63:8939-8947
33. Davies BR, O'Donnell M, Durkan GC, Rudland PS, Barraclough R, Neal DE, Mellon JK: Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 2002, 196:292-299
34. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29
35. Breen EC, Tang K: Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003, 88:848-854
36. Weston K: Reassessing the role of C-MYB in tumorigenesis. Oncogene 1999, 18:3034-3038
37. Yang JM, O'Neill P, Jin W, Foty R, Medina DJ, Xu Z, Lomas M, Arndt GM, Tang Y, Nakada M, Yan L, Hait WN: Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J Biol Chem 2006, 281:9719-9727
38. Katzenellenbogen BS, Katzenellenbogen JA: Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res 2000, 2:335-344
39. Katzenellenbogen BS, Montano MM, Le Goff P, Schodin DJ, Kraus WL, Bhardwaj B, Fujimoto N: Antiestrogens: mechanisms and actions in target cells. J Steroid Biochem Mol Biol 1995, 53:387-393
40. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA: Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007, 87:905-931
41. Clevenger CV, Furth PA, Hankinson SE, Schuler LA: The role of prolactin in mammary carcinoma. Endocr Rev 2003, 24:1-27
42. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer. J Steroid Biochem Mol Biol 1990, 37:977-981
43. Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L: Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res 1984, 44:1963-1968
44. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI, Sutherland RL: Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab 1997, 82:3692-3699
45. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE: Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol 1995, 146:695-705
46. Edery M, Imagawa W, Larson L, Nandi S: Regulation of estrogen and progesterone receptor levels in mouse mammary epithelial cells grown in serum-free collagen gel cultures. Endocrinology 1985, 116:105-112
47. Schultz JR, Petz LN, Nardulli AM: Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression. Mol Cell Endocrinol 2003, 201:165-175
48. Frasor J, Gibori G: Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 2003, 14:118-123
49. Jenkinson SR, Barraclough R, West CR, Rudland PS: S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer 2004, 90:253-262
50. de Silva Rudland S, Martin L, Roshanlall C, Winstanley J, Leinster S, Platt-Higgins A, Carroll J, West C, Barraclough R, Rudland P: Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 2006, 12:1192-1200
51. Brattsand G: Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 2000, 83:311-318
52. Guerin M, Sheng ZM, Andrieu N, Riou G: Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene 1990, 5:131-135
53. Gudas JM, Klein RC, Oka M, Cowan KH: Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Clin Cancer Res 1995, 1:235-243
54. Drabsch Y, Hugo H, Zhang R, Dowhan DH, Miao YR, Gewirtz AM, Barry SC, Ramsay RG, Gonda TJ: Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci USA 2007, 104:13762-13767
55. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O: Differential expression patterns of S100A2. S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 1997, 74:464-469
56. Murphy LC, Murphy LJ, Tsuyuki D, Duckworth ML, Shiu RP: Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum. J Biol Chem 1988, 263:2397-2401
57. Ren S, Cai HR, Li M, Furth PA: Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 2002, 21:4335-4339
58. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H: Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005, 24:746-760
59. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H: Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 2004, 22:2053-2060
60. Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV: Prolyl isomerase cyclophilin A regulation of Jak2 and the progression of human breast cancer. Cancer Res 2008, 68:7769-7778
61. Bieche I, Maucuer A, Laurendeau I, Lachkar S, Spano AJ, Frankfurter A, Levy P, Manceau V, Sobel A, Vidaud M, Curmi PA: Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP. Genomics 2003, 81:400-410
62. Ebihara T, Endo R, Kikuta H, Ishiguro N, Ma X, Shimazu M, Otoguro T, Kobayashi K: Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease. Eur J Pediatr 2005, 164:427-431